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Abstract  
Vulval skin disease is common in gynaecological practice. This article aims to enhance clinical skills in patient assessment, vulval examination 
and treatment of common benign vulval skin disease. Basic treatments are often of benefit the patient (e.g use of emollients and topical steroids), 
but many patients have complex disease and can present with more than one condition so careful assessment and individualised management is 
essential. Understanding of when to refer onwards to a vulval specialist service is important to optimize clinical outcomes. Clinical outcomes to 
consider for all patients with vulval skin disease should include 1) A reduction in symptoms (eg less itch, fewer flare-ups), 2) An improvement in 
function (eg sexual function, mobility), 3) Increased confidence in self-management (eg management of flare-ups and self-examination).  
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Main text 
Assessment of the patient  
History taking 
Most vulval skin diseases can be diagnosed on the basis of a history and clinical examination. Investing time in this process is important as some 
patients have already experienced delays in management or ineffective treatments. Discussing vulval skin problems is a sensitive subject matter 
which requires a relaxed and sympathetic environment for the patient to express their concerns. This should be recognized by the clinician and 
will improve the overall patient experience by allowing a good rapport to be established early on.  
An accurate description of symptoms and assessment of function are paramount to determine the impact of the condition on the patient. Table 1 
outlines some key questions to ask in the history and reasoning for this. A psychosexual history should be explored if appropriate as secondary 
psychosexual problems such as avoidance, phobia of touch, loss of libido and vaginismus may be identified and need addressing as a key 
aspect of the treatment plan. Clinicians may express concern at discussing sexual function with patients who have a vulval problem, but patients 
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often welcome discussing this important aspect of the history.  
 
 
Table 1 – vulval history taking points 
Question Reasoning 
What are the key symptoms and how 
severe are they?  
Important to be clear on the initial symptom. Itch can suggest skin disease or infection. Pain 
can be secondary to itching from skin damage through trauma. Vaginal discharge may suggest 
infection.  
How long has the woman been 
experiencing symptoms? 
Acute symptoms may indicate infections such vulvovaginal thrush or contact dermatitis. 
Chronic symptoms may be due to lichen sclerosus or lichen planus.  
What is the impact on the patient’s 
function? (‘How do the symptoms affect 
you?’ or ‘What do you miss as a result of 
the problem?’) 
Improvement in function (including sex) is an important clinical outcome. Functional impairment 
should be documented at every consultation 
What treatments have been tried before 
(including over the counter agents)? 
The history should explore failed treatments e.g. topical steroid frequency and amount as under 
usage with these treatments is common due to steroid phobia or a lack of understanding by the 
patient. Inappropriate topical treatments can exacerbate symptoms and potentially cause an 
irritant reaction. 
How is the patient cleaning the vulval 
area? 
Over-washing may lead to skin damage and further irritation.  
Are there any possible contacts with 
irritants e.g. soaps, shampoos, urine, and 
scented vaginal wipes?  
These are potential irritants and can damage the skin potentially causing inflammation. Urine 
and scented vaginal wipes are potent skin irritants. 
Are symptoms stress related? In lichen simplex, itching is classically worse at times of stress. Many inflammatory skin 
conditions may flare during stressful life events. 
Is there any systemic illness? For example, diabetes, renal failure, anaemia (these may all be a cause of itch), or 
autoimmune conditions (higher chance of systemic autoimmunity in lichen sclerosus or erosive 
lichen planus). A family history of autoimmunity should also be asked.. 
Are there any other skin conditions 
present? 
Skin disease at other skin sites may provide clues to the vulval diagnosis. For example, 
eczema or psoriasis. These may be very obvious, however signs may be subtle, for example 
psoriasis is sometimes hidden as cracking behind the ears, a scaly scalp or umbilical 
erythema) 
 
Vulval examination 
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Vulval examination needs to be carried out with tact and awareness of the patient’s possible discomfort. It is sensible to have a chaperone 
present, especially if the examining doctor is male. Examination should be thorough and methodical to include all areas of the vulva, perineum 
and perianal area. The patient should initially be in the dorsal position for vulval and perineal examination and subsequently turned to the left 
lateral position to examine the perianal area. Good lighting is essential to view these areas adequately. It is not necessary for the patient to be 
placed in the lithotomy position. 
The normal vulva in an adult woman includes the mons pubis, inguinal folds, outer and inner labia (majora and minora), clitoris (body and hood), 
perineum, vestibule and anus (Figure 1). Hart’s line is the junction between the vestibule and the inner labia and marks change in epithelium type 
from mucosal type to stratified squamous. Digital and speculum examinations of the vagina may be appropriate to look for erosions, mucosal 
thickening, adhesions, and scarring (1). Vulval pathology may be a manifestation of a general skin condition and therefore a complete 
examination including the umbilicus, natal cleft, oral cavity, eyes and mouth should be performed if relevant. This allows a more complete 
assessment of disease extent and diagnosis especially for diseases that are not solely restricted to the vulval region such as psoriasis, eczema, 
lichen sclerosus and erosive lichen planus. It is important to note that the classical appearances of skin conditions may not apply to the vulval 
area as it is a covered, moist environment. For example, psoriasis on normal skin presents with well demarcated, scaly erythematous plaques, 
but vulval psoriatic plaques are smooth, glossy and often salmon-pink in colour often with no scale. 
 
 
Examination may show changes in colour and texture of vulval skin or mucosa: 
 ‘Erythema’ refers to reddening of the skin, which may be poorly demarcated, as in eczema (Fig 2 demonstrates poorly defined erythema 
in the context of contact dermatitis) or well demarcated, as in psoriasis (Fig 3). The presence of erythema usually indicates an underlying 
inflammatory process. If present in association with pain, infection should be considered.   
 Whitening of the skin may occur in the presence of a normal epidermis such as in vitiligo, or in conjunction with epidermal change such as 
lichen sclerosus (Figure 5).  
 ‘Lichenification’ is the term used to describe a leathery thickening of the skin with increased skin markings which occurs in response to 
persistent rubbing. The vulval region is often moist and scale is a less reliable sign than on other areas of the skin. It is most reliable on 
the mons pubis where scale may be a manifestation of psoriasis. On other sites such as the natal cleft, scale and lichenification may 
result in whiteness and splitting of the skin. This can make common conditions more difficult to diagnose (Figure 6). 
The terms used to describe vulval lesions are described in table 2. 
 
 
Table 2: Terminology of lesions that may be seen in the vulval area 
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Lesion 
terminology 
Description Example 
Fissure A thin ‘hairline’ crack in the skin surface due to excessive 
dryness 
Psoriasis and lichen sclerosus  
Excoriation Scratch mark, may be single or multiple May be seen in any itchy skin 
condition e.g. atopic eczema, 
lichen sclerosus 
Erosion A shallow denuded area due to loss of the epidermis (surface 
layer of skin) 
Erosive lichen planus 
Ulcer Full thickness loss of the epidermis (top layer of skin) +/- dermis Aphthous ulceration 
Macule Flat area of colour change Vulval melanosis 
Ecchymosis (subcutaneous 
purpura) seen in lichen 
sclerosus 
Nodule Large palpable lesion greater than 0.5 cm in diameter Squamous cell carcinoma, 
Scabies 
Papule Small palpable lesion less than 0.5cm in diameter Genital warts 
Molluscum contagiosum 
Seborrhoeic keratosis 
Plaque A palpable flat lesion greater than 0.5 cm diameter. It may be 
elevated or may be a thickened area without being visibly raised 
above the skin surface 
Vulval Intraepithelial Neoplasia 
Squamous cell carcinoma 
Large seborrheic keratosis 
Vesicle Small fluid filled blister less than 0.5cm diameter Bullous pemphigoid 
Lichenification An accentuation of skin markings commonly associated with 
thickening of epidermis usually caused by scratching or rubbing 
Lichen simplex 
 
Investigations 
 
Diagnostic vulval biopsy 
A 4mm Keyes punch biopsy is adequate and should ideally be carried out under local anaesthetic at the initial visit if indicated. It can provide 
adequate tissue for histology but is not adequate if immunofluorescence is also required to exclude immunobullous disease when two biopsies 
may be needed. It is important to avoid crushing the epithelium when taking the biopsy as this impact on histology interpretation. Inflammatory 
vulval lesions often have indistinct inflammatory pathology and a diagnosis should always be a clinic pathological correlation. A vulval biopsy is 
usually indicated for 1), asymmetrical pigmented lesions, 2) persistently eroded areas, 3) indurated and suspicious ulcerated areas, 4) when 
there is poor response to treatment following the initial diagnosis. The site selected for biopsy should be tissue-representative of the lesion or 
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area of abnormality. This is usually at the edge of the lesion and should also include some normal tissue. The most central area may be inflamed 
or necrotic, which may give minimal tissue diagnosis because of the inflammation present.  
 
An excisional biopsy where the lesion is completely removed can be problematic if the diagnosis is subsequently found to be cancer or VIN in 
that re-excision is often required. This can lead to further skin loss that might compromise function. We would recommend a diagnostic biopsy 
only for initial assessment. If a cancer is suspected then taking a 4mm Keyes punch biopsy is acceptable or referral on to a gynaecological 
cancer team. Multiple mapping biopsies are indicated in cases of suspected multifocal disease to make a diagnosis and exclude invasion. This 
usually requires a general anaesthetic.  
 
Histopathology biopsy reports may confirm a diagnosis and also exclude malignancy. In some patients a clinical suspicion of a disease process 
can be supported (but not confirmed) by the biopsy report so it is important to correlate the report in the context of the patient’s clinical 
presentation. If there is a discrepancy between the clinical presentation and the report then the report should be reviewed with the pathologist. 
An example is the reporting of ‘inflammation’ which may be incorrectly interpreted as dermatitis and lead to the prescription of topical steroids. 
‘Inflammation’ may be over reported in normal skin and is not uncommon in other inflammatory skin conditions eg early lichen sclerosus. 
 
Vaginal and vulval swabs  
Infection with candidiasis is a common cause for loss of symptom control in inflammatory dermatoses and may be a reason why lichen sclerosus 
appears initially well controlled with potent steroids and then flares. Minor degrees of skin trauma from scratching can produce infection. 
Occasionally, genital herpes can be a cause of vulval symptoms and a viral culture swab may be necessary. Genital herpes testing may not be 
possible in the standard gynaecology clinic so referral onto genito-urinary medicine services may be appropriate. 
 
Patch testing 
Patch testing is a measure of delayed type (type IV) hypersensitivity reaction. It is carried out under the supervision of a dermatologist and is 
indicated when allergic contact dermatitis is considered. During the process, potential allergens are placed on aluminium discs and applied to the 
patient’s back. These are removed and read at 48 hours, and then again at 72 hours after application to examine for a reaction. Allergic contact 
dermatitis is difficult to diagnose clinically and clinicians need to be aware of this condition when prescribing topical treatments such as steroids. 
Common allergens in the vulval area include topical steroids, topical anaesthetics, fragrances, sodium lauryl sulphate and topical neomycin (2). 
Sensitisation leading to dermatitis can occur at any time and should be considered if symptoms initially well controlled with topical therapies 
subsequently flare. Patients should be initially referred to a vulval service or a dermatologist for an opinion if allergic contact dermatitis is 
suspected. Clinical history is very important to determine potential sensitising agents which can then be applied to the skin during the patch 
testing process.  
 
The multidisciplinary team 
As many vulval problems are chronic, rare and difficult a multidisciplinary input may be required. Service provision can vary but most hospitals in 
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the UK provide a local vulval clinic providing expert help. Members of vulval service might include dermatology, genito-urinary medicine, 
physiotherapy, pain management, psychosexual therapy, pathology and urogynaecology. 
 
 
Specific vulval skin diseases 
 
A systematic approach is required when managing patients with vulval symptoms. It is important to understand that vulval itch (sometimes 
termed ‘pruritus vulvae’) is a common presenting complaint. It is not in itself a diagnosis, but a symptom indicating an underlying cause. Itch may 
be the presenting symptom of many vulval skin disorders. It may also be related to an underlying systemic illness as part of a more generalised 
complaint of itch. Common dermatoses in the anogenital area can affect any female and include dermatitis (irritant, allergic contact or atopic), 
psoriasis and lichen sclerosis. Other important local causes of anogenital itch include infections (candidiasis, viral warts), urinary or faecal 
incontinence, lichen simplex chronicus, squamous cell carcinoma and oestrogen deficiency.  The algorithm outlined in Fig 4 is useful when 
assessing patients who present with vulval itch.  
Table 3 gives a summary of the clinical features of specific skin diseases, diagnosis and treatment and gives a framework of making a diagnosis, 
initial treatment and ongoing referral teams. With some conditions eg psoriasis, dermatologists will need to take a lead clinician role in 
management. We have included the important value of a general practitioner in management as they are usually responsible for the ongoing 
management of patients in the community.  
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Table 3 - summary of the clinical features and treatment of specific skin diseases. 
Diagnosis Clinical appearance Diagnosis Primary treatment Who should manage 
following a diagnosis?
Lichen 
sclerosus  
(auto-immmune, 
chronic, 
inflammatory 
skin condition).  
Porcelain white papules and plaques 
Ecchymoses (subcutaneous purpura) 
Erosions (loss of epidermis) 
Fissures 
Lichenification (see Fig 5)  
There can be a ‘figure of eight’ 
appearance to the disease.  
Loss of normal anatomy, labial fusion and 
adhesions are late signs of disease.   
 
Clinically if confident 
or a vulval biopsy. 
Consider biopsy(s) 
if there are 
indurated or 
suspicious areas  
 
 
Superpotent topical steroid 
and emollients (see Topical 
steroids and their use in the 
treatment of vulval skin 
conditions) 
There is a small risk of 
cancer (less than 5% risk) so 
patients should be 
encouraged to self exam on a 
regular (suggested monthly) 
basis. 
Posterior fourchette fissuring 
may require digital massage 
of the steroid into the fissure, 
vaginal dilators, lubricants 
and possible surgery (Z-
plasty).  
Gynaecologist, 
dermatologist or GP. 
Refer to vulval service for 
treatment resistant 
cases, complications of 
treatment and when 
associated with VIN.  
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Lichen planus 
(autoimmune 
chronic 
inflammatory 
condition)  
 
Two types can affect the vulva 
‘Classical’ lichen planus - violaceous, well 
demarcated plaques with overlying lacy 
white lines which usually affect the labia 
majora and surrounding skin 
 
Erosive lichen planus -  ‘glazed’ erythema 
or erosions symmetrically distributed at 
vaginal introitus. White slightly raised 
edge to lesions. Lacy white lines 
(Wickham’s striae) in surrounding skin. 
(see Fig 6). May have loss of anatomy. 
Pain is usually a presenting feature and 
these patients can also have significant 
vaginal stenosis 
Clinical assessment 
and biopsy from the 
edge of an erosion.  
Lichen planus may 
be seen in the 
mouth or normal 
skin 
Superpotent topical steroid 
and emollients (see Topical 
steroids and their use in the 
treatment of vulval skin 
conditions) 
 
. 
Dermatologist or 
gynaecologist. For 
classical type refer to 
vulval service for 
treatment resistant cases 
and when associated 
with VIN. Erosive lichen 
planus is difficult to treat 
so refer early to a vulval 
service. 
Atopic eczema 
(may be termed  
Atopic 
dermatitis) 
Symmetrically inflamed, erythematous, 
weepy skin.  No loss of anatomy. May be 
satellite lesions and poorly defined edges. 
Lichenification may be present 
Figure 2 shows the appearance of vulval 
eczema that might be due to either atopic 
eczema or contact dermatitis 
Clinical history and 
examination to 
include other skin 
sites for other signs 
of eczema 
especially the 
antecubital and 
popliteal fossae. 
The skin is often 
noticeably dry.  
Moderate (e.g clobetasone 
butyrate 0.05%) or potent 
(e.g. Mometasone furoate 
0.1%) topical steroid plus 
emollients to gain control of 
inflammation. 
 
Dermatologist or GP 
Contact 
dermatitis 
Two types can affect the vulva 
Irritant form (triggered by irritants eg 
soap, urine) Poorly defined erythema 
present where irritant has been applied 
Allergic form – Erythema extends outside 
of area where allergen has been applied 
Figure 2 shows the appearance of vulval 
eczema that might be due to either atopic 
eczema or contact dermatitis 
Clinical history and 
examination. 
Patch testing if 
allergic contact 
dermatitis 
suspected 
Moderate (e.g clobetasone 
butyrate 0.05%) or potent 
(e.g. Mometasone furoate 
0.1%) topical steroid plus 
emollients to gain control of 
inflammation. 
Strict avoidance of 
irritants/allergens. 
Dermatologist and GP 
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Seborrhoeic 
eczema 
Glazed skin in the intralabial sulci.  Clinical examination 
of other sites – 
scalp, eyebrows, 
nasolabial folds for 
erythema and fine 
scaling 
Moderate (e.g clobetasone 
butyrate 0.05%) or potent 
(e.g. Mometasone furoate 
0.1%) topical steroid plus 
emollients to gain control of 
inflammation. 
 
Dermatologist and GP 
 
 
Psoriasis 
 
Classically, well demarcated, scaly 
erythematous plaques, but vulval 
psoriatic plaques are smooth, glossy and 
often salmon-pink in colour. Often no 
scale in vulval creases but surrounding 
skin may have typical scaly lesions of 
psoriasis. There is no scarring or loss of 
anatomy (Fig 3). 
Clinical assessment 
to include 
examination of 
‘hidden sites’ for 
other signs of 
psoriasis eg . 
knees, elbows, 
umbilicus, scalp, 
ears, lower back 
and nails Biopsy if 
unsure. 
Moderate potency topical 
steroid plus emollients as 
recommended by NICE 
guidance. As the skin folds 
can become particularly 
macerated, there is a chance 
of secondary bacterial or 
fungal infection. A 
combination topical 
preparation (e.g clobetasone 
butyrate 
0.05%/oxytetracycline 
3%/nystatin) may be helpful. 
Dermatologist 
Lichen simplex  
 
 
Lichenification of the skin with erosions 
from chronic scratching. 
Usually no loss of anatomy but can give 
thick ‘leathery’ skin. This is often 
superimposed on other itchy skin 
disorders such as eczema and lichen 
sclerosus (figure 6) 
 
Clinical history and 
examination. 
 
Superpotent topical steroid 
and emollient. Once control 
of symptoms is achieved, 
moderate potency topical 
steroid may be required 
intermittently. Secondary 
infection with candida or 
bacteria is common and may 
need treatment. 
Dermatologist and GP. 
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Management of vulval skin conditions 
 
General principles 
Initial principles of management are the same for all vulval skin conditions and a holistic approach is required. Good education, support and 
counselling are needed with extra time given to address the disease process, discussing general vulval care measures and managing 
expectations. It is useful to provide information leaflets, direct patients to relevant patient-oriented websites and write down instructions for 
applying topical agents.(see ‘Additional resources’ for sources of patient information). The use of a mirror or model in the clinic setting is helpful 
to show patients where to apply their topical treatments. 
 
Correct barrier function  
Most vulval skin conditions are characterised by skin or mucosal barrier breakdown as well as underlying inflammation. Correction of the 
epidermal barrier is important in helping to reduce inflammation. For washing, soap and other routine cleaning agents (e.g. wipes) should be 
avoided, as they are likely to act as irritants or allergens. Irritation from urinary and faecal incontinence needs to be addressed as these are a 
common cause of irritation and make underlying skin pathology worse. ‘Soap substitution’ with a bland cream or ointment based emollient is best 
for cleansing. The same agent can then be used as a moisturiser to both provide a barrier to the site and sooth inflamed skin. There is no 
preferred emollient to use and the best one is the one the patient will adhere to. Emollient creams (not ointments) can be placed in the fridge as 
this can help sooth the skin. 
 
Using of topical steroids on the vulva 
Topical steroids reduce inflammation associated with skin diseases such as lichen planus, lichen sclerosus and eczema leading to improvement 
in symptoms and appearance. However, there are patient and physician concerns at the use of topical steroids due to worry about side-effects, 
particularly skin or mucosal atrophy, which can lead to undertreatment and less control of symptoms. It is important therefore to use the correct 
strength of topical steroid for the necessary length of time on the appropriate body site with the clear instructions to patient so that they can be 
confident in self-management and be reassured that when applied correctly ‘skin thinning’ is very unlikely. Mucosal surfaces such as the vulval 
vestibule are remarkably resistant to steroid atrophy. Table 3 outlines the recommended potency of topical steroid for treatment of inflammatory 
conditions frequently seen in the vulval clinic. 
 
In lichen sclerosus and lichen planus, the use of superpotent topical steroids is recommended as first-line therapy. A recent Cochrane systematic 
review showed there is reasonable randomised controlled trial evidence for the use of topical steroids in lichen sclerosus and The British 
Association of Dermatologists suggest the use of the superpotent topical steroid, clobetasol proprionate 0.05%, over a three-month reducing 
course (suggested daily for one month, alternate days for month and twice a week maintenance) (3,4). There are currently no specific guidelines 
for lichen planus, but the standard practice is to use a similar regimen as for lichen sclerosus and case series evidence supports this (5). In 
general topical steroids should be used once-daily. There is no evidence to suggest that twice-daily application is superior, although twice-daily 
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has greater potential to cause side effects. Ointments are preferable to creams as they contain fewer constituents and therefore have a lower 
chance of causing irritation/contact allergy. Once control of inflammation and symptoms has been achieved, topical steroids should be reduced 
to the minimum frequency required to maintain remission. The concept of ‘weekend therapy’, that is, applying topical steroids on two consecutive 
days per week, is effective in atopic eczema patients  and can extrapolated to chronic vulval diseases such as lichen sclerosus and lichen planus 
where long-term maintenance therapy is required. A patient with these conditions will use approximately 30-60 g of topical steroid per year as 
maintenance therapy. Topical steroids should only be used on affected areas to prevent side-effects in adjacent skin. Table 4 outlines reasons 
why there may be a failure to respond to topical steroid treatments. 
 
Table 4 – Reasons why there may be a failure to respond to topical steroid treatments within vulval skin conditions 
 Continued exposure to irritants – eg urine or faeces, external products such as wipes or non-prescribed topical treatments and over 
washing with water can all contribute towards irritation and ongoing symptoms. 
 Poor adherence to prescribed treatment regimen –The patient should be advised to apply the topical steroid in terms of the finger tip 
unit (A finger tip is from the very end of the finger to the first crease in the finger. It does NOT mean a blob on the fingertip). The number 
of fingertip units required is usually one to two but is specifically tailored to the patient depending upon surface area affected by the 
condition. 
 Inaccurate placement of topical steroid – the patient may be applying the topical treatment to an unaffected area. Especially common if 
the patient is elderly and unable to use a mirror to see what they are doing.  
 Incorrect diagnosis – if adherence and skin care practices are assessed as adequate, it may be that the diagnosis given is incorrect. An 
allergic contact dermatitis to topical treatments may have occurred (see section on Patch Testing) or there may be pre-malignant or 
malignant change in the affected area. If there is any concern a biopsy should be taken 
 An inappropriate and/or weak steroid has been prescribed eg 1% hydrocortisone. Reducing the potency of the steroid ointment is not 
usually practiced and it is more usual to reduce the frequency of application of the suprapotent steroid.  
 Superimposed infection – eg candidiasis. 
 
 
Good practice points 
 
 Take a thorough symptom and function history and perform a systematic examination 
 Describe vulval conditions in dermatological terminology to support the diagnosis 
 Avoid empirical prescriptions before there is clinical evidence to support the diagnosis 
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 Provide written information and clear instructions to the patient where possible especially with regards the use of topical corticosteroids 
 Employ a low threshold for a vulval biopsy if there is any doubt the diagnosis 
 
 
 
 
Conclusion 
Core competencies in vulval disease for the general gynaecologist should include being able to take a detailed patient history and examination, 
make a diagnosis and starting basic treatment. It is important to underpin the treatments with clear explanation to the patient on vulval care and 
the use of topical steroids to improve clinical outcomes. Complex, rare and treatment resistant patients should be referred to a vulval service. 
 
Further resources; 
Dermnetnz: The Dermatology Resource www.dermnetnz.org 
British Society for the Study of Vulval Disease www.bssvd.org 
Online resource endorsed by the ISSVD http://vulvovaginaldisorders.com/ 
Online training course which is free to UK doctors to access www.e-lfh.org.uk/projects/dermatology/index.html 
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FIGURES 
Figure 1: Schematic representation of the normal adult vulva. Copyright  “Dawn Danby and Paul Waggoner”, c/o ISSVD 
Figure 2: Vulval eczema (dermatitis). Note poorly defined erythema of the genitocrural skin, erosions due to excoriation in the inflamed skin and 
white thickening (lichenification) of the labia majora due to scratching. This appearance may be due to atopic eczema, or an external cause as in 
contact dermatitis (either irritant or allergic contact dermatitis). 
Figure 3: Psoriasis affecting the female genitalia. Well demarcated erythema surrounding the anogenital area with typical psoriatic plaques in 
surrounding skin. The genital plaque has typical scale in the perianal area, but lack of scale in the perineal and vulval areas. 
Figure 4– algorithm for the management of vulval itching 
Figure 5: Advanced vulval lichen sclerosus. Whiteness, loss of anatomy, ecchymosis seen on the left labia, scarring over the clitoral hood 
Figure 6: Skin lichenification 
Figure 7. Erosive lichen planus. Well demarcated symmetrical erosions present at the vaginal introitus. Note anatomical changes with loss of the 
labia minora and clitoral hood, anterior fusion and narrowing of the vaginal opening. 
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Fig 4– algorithm for the management of vulval itching 
 
 
  
Vulval itch 
Normal  
architecture? 
Vaginal discharge 
or 
Weeping of skin 
Suspicious features  
(consider cancer/VIN) 
Take biopsy 
Lichen sclerosus/ 
Lichen planus 
Eczema/ psoriasis 
Swab and treat 
Vulval care regimen; 
Moderate potency 
Topical steroid 
Refer for diagnosis, ongoing inves ga on and treatment if not confident 
(if suspected cancer refer via appropriate pathway) 
Vulval care regimen; Treat 
if confident with super 
potency topical steroid 
No Yes 
If inadequate response 
Is there  
Candidiasis? 
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MCQ questions True False 
 
 
With regards vulval inflammatory skin conditions, 
 
a. Vulval psoriasis should be treated with a superpotent topical steroid 
 
b. Side effects from topical steroid use are uncommon 
 
c. Dermatologist patch testing should be considered for all patients with recurrent vulval itching 
 
d. Erosive lichen planus presents with pain rather than itch 
 
e. The risk of squamous cell carcinoma development in lichen sclerosus is 10% 
 
Answers to question  
(a) F    (b) T   (c) F    (d) T    (e) F 
 
Explanation to answers   
NICE guidance recommends that moderate potency topical steroids are used for vulval psoriasis, 
With regards the topical use of steroids on the vulva, If an appropriate strength and frequency of topical steroid are used, side effects such as 
atrophy and striae are uncommon (less than 5%). Dermatologist patch testing should be considered for only for those patients where allergic 
contact dermatitis require exclusion. Erosive lichen planus is usually painful due to mucosal erosion. Classical lichen planus is itchy, the erosive 
variant of lichen planus is painful. The risk of squamous cell carcinoma development in lichen sclerosus is less than 5%. 
 
 
With regards skin lesion morphology 
 
a. A papule is a small palpable lesion less than 0.5cm in diameter 
 
b. An ulcer is a shallow denuded area due to loss of the epidermis (surface layer of skin) 
 
c. Patients with vulval skin lichenification usually have painful, thickened skin in the area scratching 
d. A vesicle is a small fluid filled blister less than 0.5cm diameter 
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e. Vulval intraepithelial neoplasia may be plaque-like 
Answers to question  
(a) T    (b) F   (c) F    (d) T    (e) T 
Explanation to answers   
An erosion is a shallow denuded area due to loss of the epidermis (surface layer of skin). Pruritus is usually the main symptom with 
lichenification and secondary pain may be present if the skin is broken through scratching. Vulval intraepithelial neoplasia has not been covered 
in this article but can present in a variety of dermatological forms but is usually plaque –like.  
 
